Johnson & Johnson Share Price Today
(NASDAQ: JNJ)

Name: Johnson & Johnson Share Price Today (NASDAQ: JNJ) - Johnson & Johnson Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Johnson & Johnson share price is $153.49 & ₹13,368.21 as on 6 Feb 2025, 2.30 'hrs' IST

$153.49

▲

1.62

(1.07%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Johnson & Johnson share price in Dollar and Rupees. Guide to invest in Johnson & Johnson stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Johnson & Johnson, along with analyst recommendations, forecasts, and comprehensive financials.

Johnson & Johnson share price movements

Today's Low: $151.04
Today's High: $154.18
$153.49
1.6%
Downside
Day's Volatility :2.04%
Upside
0.45%
52 Weeks Low: $140.68
52 Weeks High: $168.85
$153.49
8.35%
Downside
52 Weeks Volatility :16.68%
Upside
9.1%

Johnson & Johnson (JNJ) Returns

Period	Johnson & Johnson	Sector (Health Care)	Index (NASDAQ Composite)
3 Months	-3.81%	0.5%	6.3%
6 Months	-4.42%	-2.3%	11.8%
1 Year	-3.92%	3.8%	14.9%
3 Years	-11.22%	11.4%	26.6%

Johnson & Johnson (JNJ) Key Statistics

in dollars & INR

Previous Close	$151.87
Open	$151.36
Today's High	$154.18
Today's Low	$151.04
Market Capitalization	$366.3B
Today's Volume	$6.1M
52 Week High	$168.85
52 Week Low	$140.68
Revenue TTM	$87.7B
EBITDA	$30.1B
Earnings Per Share (EPS)	$5.8
PE Ratio	26.23
Dividend Yield	3.35%
Profit Margin	16.74%
Quarterly Earnings Growth YOY	-0.89%
Return On Equity TTM	20.89%

How to invest in Johnson & Johnson Stock (JNJ) from India?

It is very easy for Indian residents to invest directly in Johnson & Johnson from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Johnson & Johnson stock in both Indian Rupees (INR) and US Dollars (USD). Search for Johnson & Johnson or JNJ on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Johnson & Johnson or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Johnson & Johnson shares which would translate to 0.006 fractional shares of Johnson & Johnson as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Johnson & Johnson, in just a few clicks!

Returns in Johnson & Johnson (JNJ) for Indian investors in Rupees

The Johnson & Johnson stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Johnson & Johnson investment value today

Current value as on today

₹1,01,973

Returns

₹1,973

(+1.97%)

Returns from Johnson & Johnson Stock

₹2,891 (-2.89%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Johnson & Johnson (JNJ)

-22.01%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Investment in Johnson & Johnson Shares from India has dropped by -22.01% over the past 30 days, indicating reduced transactional activity.

10%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Johnson & Johnson Stock from India on INDmoney has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Johnson & Johnson Stock (JNJ Ticker)

Name	Shares Held	Change in Shares	% of Assets
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	3630	0.00	2.84%
Motilal Oswal S&P 500 Index Fund Direct Growth	20769	-1456.53	0.69%

Global Institutional Holdings in Johnson & Johnson

Vanguard Group Inc
9.60%
BlackRock Inc
8.31%
State Street Corp
5.58%
JPMorgan Chase & Co
2.83%
Geode Capital Management, LLC
2.33%
Morgan Stanley - Brokerage Accounts
1.88%

Analyst Recommendation on Johnson & Johnson

Buy

53%Buy

46%Hold

0%Sell

Based on 28 Wall street analysts offering stock ratings for Johnson & Johnson(by analysts ranked 0 to 5 stars)

Based on 28 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Johnson & Johnson Stock (JNJ)

What analysts predicted

Upside of 9.75%

Target:

$168.45

Current:

$153.49

Insights on Johnson & Johnson Stock (Ticker Symbol: JNJ)

Price Movement
In the last 7 days, JNJ stock has moved up by 1.0%
Increasing Revenue
Johnson & Johnson has shown consistent revenue growth over the last three quarters. Their revenue increased from $21.38 billion to $22.47 billion, which represents an average quarterly growth rate of 2.4%.
Decreasing Net Profit
Johnson & Johnson has experienced a decline in its net profit over the last two quarters. The company's net profit decreased from $4.68 billion to $2.69 billion, indicating an average drop of 42.5% per quarter.
JNJ vs PG (1 yr)
In the last 1 year, Procter & Gamble Company, The has given 6.7% return, outperforming this stock by 9.7%
JNJ vs PG (3 yr)
In the last 3 years, Procter & Gamble Company, The has given 4.5% return, outperforming this stock by 16.0%
Price to Sales
Johnson & Johnson's Price-to-Sales Ratio indicates that investors are willing to pay $4.20 for every $1 of sales generated by the company. In comparison, investors are paying $4.70 for every $1 of sales for Procter & Gamble Company. This suggests that Johnson & Johnson is valued slightly lower than Procter & Gamble based on their sales.

JNJ Johnson & Johnson Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$81.6B	↑ 6.71%
Net Income	$15.3B	↑ 1076.69%
Net Profit Margin	18.75%	↑ 17.05%

	FY19	Y/Y Change
Revenue	$82.1B	↑ 0.59%
Net Income	$15.1B	↓ 1.16%
Net Profit Margin	18.42%	↓ 0.33%

	FY20	Y/Y Change
Revenue	$82.6B	↑ 0.64%
Net Income	$14.7B	↓ 2.68%
Net Profit Margin	17.82%	↓ 0.6%

	FY21	Y/Y Change
Revenue	$78.7B	↓ 4.65%
Net Income	$20.9B	↑ 41.89%
Net Profit Margin	26.52%	↑ 8.7%

	FY22	Y/Y Change
Revenue	$80.0B	↑ 1.59%
Net Income	$17.9B	↓ 14.07%
Net Profit Margin	22.43%	↓ 4.09%

	FY23	Y/Y Change
Revenue	$85.2B	↑ 6.46%
Net Income	$35.2B	↑ 95.94%
Net Profit Margin	41.28%	↑ 18.85%

	Q2 FY23	Q/Q Change
Revenue	$25.5B	↑ 3.28%
Net Income	$5.1B	↓ 7664.71%
Net Profit Margin	20.14%	↑ 20.41%

	Q3 FY23	Q/Q Change
Revenue	$21.4B	↓ 16.42%
Net Income	$26.0B	↑ 405.99%
Net Profit Margin	121.91%	↑ 101.77%

	Q4 FY23	Q/Q Change
Revenue	$21.4B	↑ 0.21%
Net Income	$4.0B	↓ 84.44%
Net Profit Margin	18.92%	↓ 102.99%

	Q1 FY24	Q/Q Change
Revenue	$21.4B	↓ 0.06%
Net Income	$3.3B	↓ 19.61%
Net Profit Margin	15.22%	↓ 3.7%

	Q2 FY24	Q/Q Change
Revenue	$22.4B	↑ 4.98%
Net Income	$4.7B	↑ 43.96%
Net Profit Margin	20.88%	↑ 5.66%

	Q3 FY24	Q/Q Change
Revenue	$22.5B	↑ 0.11%
Net Income	$2.7B	↓ 42.51%
Net Profit Margin	11.99%	↓ 8.89%

	FY18	Y/Y Change
Profit	$54.5B	↑ 6.64%

	FY19	Y/Y Change
Profit	$54.5B	↑ 0.02%

	FY20	Y/Y Change
Profit	$54.2B	↓ 0.63%

	FY21	Y/Y Change
Profit	$55.3B	↑ 2.18%

	FY22	Y/Y Change
Profit	$55.4B	↑ 0.1%

	FY23	Y/Y Change
Profit	$58.4B	↑ 5.45%

	Q2 FY23	Q/Q Change
Profit	$17.4B	↑ 5.48%

	Q3 FY23	Q/Q Change
Profit	$14.7B	↓ 15.21%

	Q4 FY23	Q/Q Change
Profit	$14.6B	↓ 1.0%

	Q1 FY24	Q/Q Change
Profit	$14.9B	↑ 1.88%

	Q2 FY24	Q/Q Change
Profit	$15.6B	↑ 4.75%

	Q3 FY24	Q/Q Change
Profit	$15.5B	↓ 0.45%

	FY18	Y/Y Change
Operating Cash Flow	$22.2B	↑ 5.44%
Investing Cash Flow	$-3.2B	↓ 78.7%
Financing Cash Flow	$-18.5B	↑ 141.24%

	FY19	Y/Y Change
Operating Cash Flow	$23.4B	↑ 5.47%
Investing Cash Flow	$-6.2B	↑ 95.58%
Financing Cash Flow	$-18.0B	↓ 2.67%

	FY20	Y/Y Change
Operating Cash Flow	$23.5B	↑ 0.51%
Investing Cash Flow	$-20.8B	↑ 236.21%
Financing Cash Flow	$-6.1B	↓ 66.03%

	FY21	Y/Y Change
Operating Cash Flow	$23.4B	↓ 0.54%
Investing Cash Flow	$-8.7B	↓ 58.3%
Financing Cash Flow	$-14.0B	↑ 129.53%

	FY22	Y/Y Change
Operating Cash Flow	$21.2B	↓ 9.47%
Investing Cash Flow	$-12.4B	↑ 42.47%
Financing Cash Flow	$-8.9B	↓ 36.85%

	FY23	Y/Y Change
Operating Cash Flow	$22.8B	↑ 7.54%
Investing Cash Flow	$878.0M	↓ 107.1%
Financing Cash Flow	$-15.8B	↑ 78.39%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$4.2B	↑ 28.4%
Investing Cash Flow	$-3.8B	↓ 213.91%
Financing Cash Flow	$-6.0B	↓ 197.61%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.5B	↑ 79.08%
Investing Cash Flow	$2.5B	↓ 167.29%
Financing Cash Flow	$-11.3B	↑ 88.9%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$7.9B	↑ 4.99%
Investing Cash Flow	$-1.2B	↓ 147.3%
Financing Cash Flow	$-4.7B	↓ 58.87%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$3.7B	↓ 53.49%
Investing Cash Flow	$-464.0M	↓ 61.4%
Financing Cash Flow	$546.0M	↓ 111.73%

Johnson & Johnson Technicals Summary

Sell

Neutral

Buy

Johnson & Johnson is currently in a neutral trading position according to technical analysis indicators.

Johnson & Johnson (JNJ) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Johnson & Johnson	5.71%	-4.42%	-3.92%	-11.22%	-0.01%
Procter & Gamble Company, The	5.08%	-0.74%	6.17%	5.26%	33.85%
Pfizer Inc.	-2.57%	-9.19%	-4.73%	-50.76%	-31.14%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Johnson & Johnson	26.23	26.23	0.96	10.55	0.21	0.08	0.03	29.14
Procter & Gamble Company, The	26.92	26.92	3.52	6.93	0.29	0.11	0.02	21.0
Pfizer Inc.	35.36	35.36	0.2	2.93	0.05	0.03	0.06	16.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Johnson & Johnson	Buy	$366.3B	-0.01%	26.23	16.74%
Procter & Gamble Company, The	Buy	$395.7B	33.85%	26.92	17.06%
Pfizer Inc.	Hold	$150.3B	-31.14%	35.36	7.16%

Johnson & Johnson Dividend announcements

Johnson & Johnson Dividends March, 2025
In the quarter ending March,2025. Johnson & Johnson has declared dividend of $1.24
Read More

About Johnson & Johnson

Johnson & Johnson - a multinational corporation founded in America - mainly caters to medical and consumer goods. The company's headquarters are in New Jersey, United States. The company was incorporated in 1886 by James, Robert, and Edward Mead Johnson. Johnson & Johnson is one of the world's most valuable corporations. It has nearly 250 subsidiary companies operating across 60 countries. Its products are selling in over 175 countries. Some well-known consumer products of Johnson & Johnson are Band-Aids, baby products, Tylenol medications, and other products. In 2020, Johnson & Johnson generated annual revenue of $82.584 billion. Joaquin Duato serves as the Chairman and CEO for Johnson & Johnson, along with Paul Stoffels as Vice Chairman of the Executive Committee for the company with several other members. The company was ranked 36 on the Fortune 500 list of the top corporations in the United States by total revenue in 2021. Johnson & Johnson is publicly traded on New York Stock Exchange as JNJ as its stock symbol, under the DJIA, S&P 100, and S&P 500. Currently Johnson & Johnson has a market cap of $395.34 Billion. It has a P.E ratio of 10.4. The shares of Johnson & Johnson are trading at $151.87. .

Organization	Johnson & Johnson
Employees	131900
CEO	Mr. Joaquin Duato
Industry	Health Technology

Management People of Johnson & Johnson

Name	Title
Mr. Joaquin Duato	CEO & Chairman
Mr. Joseph J. Wolk CPA	Executive VP & CFO
Ms. Jennifer L. Taubert	Executive VP & Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D.	Executive Vice President of Innovative Medicine, R&D
Mr. Robert J. Decker Jr.	Controller & Chief Accounting Officer
Mr. James Swanson	Executive VP & Chief Information Officer
Ms. Jessica Moore	Vice President of Investor Relations
Mr. Dirk Brinckman	Chief Compliance Officer
Ms. Elizabeth Forminard J.D.	Executive VP & Chief Legal Officer
Dr. Guy J. Lebeau M.D.	Group Chairman of MD&D Business - EMEA

Important FAQs about investing in JNJ Stock from India :

What is Johnson & Johnson share price today?

Johnson & Johnson share price today stands at $153.49, Open: $151.36 ; Previous Close: $151.87 ; High: $154.18 ; Low: $151.04 ; 52 Week High: $168.85 ; 52 Week Low: $140.68.

The stock opens at $151.36, after a previous close of $151.87. The stock reached a daily high of $154.18 and a low of $151.04, with a 52-week high of $168.85 and a 52-week low of $140.68.

Can Indians buy Johnson & Johnson shares?

Yes, Indians can invest in the Johnson & Johnson (JNJ) from India.

With INDmoney, you can buy Johnson & Johnson at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Johnson & Johnson at zero transaction cost.

How can I buy Johnson & Johnson shares from India?

It is very easy to buy Johnson & Johnson from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Johnson & Johnson (JNJ) be purchased?

Yes, you can buy fractional shares of Johnson & Johnson with INDmoney app.

What are the documents required to start investing in Johnson & Johnson stocks?

To start investing in Johnson & Johnson, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.